StockIQ.techHumana Inc. (HUM) Stock Analysis
Free AI-powered analysis and research for Humana Inc. stock
Sector: Healthcare
HUM snapshot
Data as of 3 Nov 2026 close. Updated daily.
Humana Inc. scores 54/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 86% of its 52-week range, up 48.1% over the past year. Latest reported figures show a profit margin of 0.9%, return on equity of 6.9% and revenue growth of +26.2%.
What is driving the score
- RSI Neutral: +5
- Uptrend: +4
- MACD Bearish: -8
- High P/E (39.2): -10
- Strong Revenue Growth (26.2%): +8
- Weak Profit Margin (0.9%): -8
- Strong Long-term Uptrend: +8
- Strong Momentum (+48.1% over 1 year): +8
- Low Volume (0.3x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full HUM report
Humana Inc. (HUM) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze HUM Now →📰 Latest Update
Why Humana (HUM) Could Beat Earnings Estimates Again
Mon, November 2, 2026 at 4:10 PM UTC 2 min read
Humana (HUM) has a strong track record of beating earnings estimates, with an average surprise of 12.88% over the last two quarters. For its most recent quarter, Humana reported earnings of $7.61 per share, exceeding expectations of $6.22 by 22.35%. With a positive Earnings ESP of +3.33% and a Zacks Rank #2 (Buy), analysts suggest that Humana is well-positioned for another earnings beat in its upcoming report on November 6, 2026.